Toggle SGML Header (+)

Section 1: 8-K (FORM 8-K)










Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): December 5, 2018





(Exact name of registrant as specified in its charter)



                 Delaware                                   0-23695                                   04-3402944                 

(State or other jurisdiction

of incorporation)

(Commission File No.)

(I.R.S. employer

Identification No.)


     131 Clarendon Street, Boston Massachusetts           02116      
(Address of principal executive offices)

(Zip Code)


(617) 425-4600

(Registrant's telephone number, including area code)


Not applicable

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


[  ]       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


[  ]       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


[  ]       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


[  ]       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark if the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company ☐


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


(b) On December 5, 2018, the Board of Directors of Brookline Bancorp, Inc. (the “Company”) accepted the resignation of Rosamond B. Vaule as director of the Company for personal reasons effective as of December 31, 2018. Ms. Vaule’s resignation did not result from any disagreements with the Company on any matter relating to its operations, policies or practices. Effective upon Ms. Vaule’s resignation as a director, the size of the Company’s Board of Directors will be reduced from fifteen to fourteen directors.


Ms. Vaule has also resigned from the Board of Directors of Brookline Bank.








Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.




Date:  December 6, 2018 By: /s/ Michael W. McCurdy  
    Chief Risk Officer, General Counsel and Secretary




(Back To Top)